ID: ALA5207426

Max Phase: Preclinical

Molecular Formula: C19H12ClN3O3

Molecular Weight: 365.78

Associated Items:

Representations

Canonical SMILES:  N#Cc1cc(-c2ncc(C(=O)O)cn2)ccc1OCc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C19H12ClN3O3/c20-16-4-1-12(2-5-16)11-26-17-6-3-13(7-14(17)8-21)18-22-9-15(10-23-18)19(24)25/h1-7,9-10H,11H2,(H,24,25)

Standard InChI Key:  ZFDLCRWMTXDSMU-UHFFFAOYSA-N

Associated Targets(Human)

Xanthine dehydrogenase 1038 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 365.78Molecular Weight (Monoisotopic): 365.0567AlogP: 3.95#Rotatable Bonds: 5
Polar Surface Area: 96.10Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.84CX Basic pKa: 1.02CX LogP: 3.92CX LogD: 0.64
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -1.29

References

1. Zhao J, Mao Q, Lin F, Zhang B, Sun M, Zhang T, Wang S..  (2022)  Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.,  229  [PMID:34992040] [10.1016/j.ejmech.2021.114086]

Source